Secondary hyperparathyroidism is not always an obstacle to improved growth during recombinant human growth hormone treatment.
Picca
S
S
Perruzza
I
I
Cappa
M
M
Rizzoni
G
G
D000293:Adolescent; D002648:Child; D012080:Chronic Kidney Disease-Mineral and Bone Disorder / Q000097:blood / Q000188:drug therapy; D005260:Female; D006130:Growth Disorders / Q000097:blood / Q000188:drug therapy*; D013006:Growth Hormone / Q000627:therapeutic use*; D006801:Humans; D006962:Hyperparathyroidism, Secondary / Q000097:blood / Q000503:physiopathology*; D008297:Male; D010281:Parathyroid Hormone / Q000097:blood; D006435:Renal Dialysis; D012189:Retrospective Studies
D010281:Parathyroid Hormone; D013006:Growth Hormone